Segmental Infantile Hemangioma With Possible PHACE Syndrome
A 3-month-old girl is brought in for a 4 cm segmental infantile hemangioma involving the right forehead and upper eyelid. It is superficial and deep, with mild ptosis but no visual axis obstruction. She was born at 34 weeks and weighs 5 kg. There is no stridor or respiratory distress. The hemangioma has grown rapidly over the past four weeks. Cardiac examination is normal; blood pressure is normal. The parents are worried about 'blood pressure medicine' and ask whether topical drops would suffice. The infant has not had neuroimaging. You are considering oral propranolol.
1. What pretreatment evaluation is indicated because of the location and size, and how does it change your start date?
Read the worked answer
A segmental facial hemangioma in the frontotemporal distribution raises concern for PHACE syndrome, especially with rapid growth and a size approaching the high-risk range. Obtain MRI and MRA of the brain and neck to evaluate posterior fossa and arterial anomalies, echocardiography to assess for coarctation and cardiac defects, and a formal ophthalmologic examination. Because the hemangioma is periocular and causing ptosis, ophthalmology should also assess refractive error and amblyopia risk. If imaging shows a cerebrovascular anomaly, coordinate with neurology; propranolol is still often used, but monitoring and risk counseling change. Do not delay treatment indefinitely while awaiting every test if the airway or vision is threatened. In a stable infant, arrange the studies urgently and start propranolol once baseline heart rate, blood pressure, and feeding status are documented.
2. How do you initiate and monitor propranolol, and what feeding advice reduces hypoglycemia risk?
Read the worked answer
Start propranolol at approximately 1 mg/kg/day divided into two or three doses, then increase gradually to 2 to 3 mg/kg/day as tolerated, with heart rate and blood pressure checked before and after initial doses. Many healthy infants do not require routine ECG, but obtain one if there is bradycardia, arrhythmia, or cardiac history. Feed regularly and give doses with feeds; avoid long fasting periods, especially during illness. Teach parents the signs of hypoglycemia, including sweating, irritability, lethargy, poor feeding, and seizures, and tell them to hold the dose and seek care if the infant is not feeding well. Do not stop abruptly because of rebound and beta-blocker withdrawal. Topical timolol is insufficient for this large, deep, periocular lesion with ptosis.
3. At 6 months, the hemangioma is flat and ptosis has resolved. What is the tapering plan, and why not stop abruptly?
Read the worked answer
Do not stop propranolol abruptly. Although the lesion has flattened, involution continues through approximately 12 to 18 months, and early cessation can cause rebound growth. Continue treatment until at least 12 months of age, often longer for a segmental periocular lesion, then taper over two to four weeks while monitoring for rebound. Abrupt withdrawal can also cause sympathetic overactivity such as tachycardia and hypertension. At each visit, assess size, color, and ptosis, and confirm that vision and refractive status remain normal. If rebound occurs during tapering, return to the prior effective dose and taper more slowly. Document the rationale for prolonged therapy so the family does not interpret continued treatment as overtreatment.